Torrent Pharmaceuticals Limited
NSE: TORNTPHARMINE685A01028·HealthcareNifty Next 50·www.torrentpharma.com ↗·Mcap ₹1.89L Cr·Listed 2002
₹4,988.50▲ ₹60.00  (1.22%)
52W: ₹3,481 – ₹5,250 · Vol: 3.9L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19Q3 FY19Q2 FY19Q1 FY19Q4 FY18
Revenue from operations4,9214,1973,3033,3023,1782,9592,8092,8892,8592,7452,7322,6602,5912,4912,4912,2912,1312,1082,1372,1341,9371,9952,0172,0561,9461,9662,0052,0221,8562,0511,8941,8721,722
Other income−12−17−13−27−37−1833−162431−3326349−1016564851403986415533420173102742
Total expenses4,1553,5852,4662,4712,4032,2522,1512,2122,2272,1452,1562,1272,0942,0672,0621,8441,7891,7991,7161,6901,5931,6461,6391,6581,6681,7001,7431,7631,6661,7791,6991,6671,630
EBITDA1,6641,3561,0881,0831,032964914939904883869825791727724679561538660677582607635661548540541541473561473477364
EBITDA margin33.8%32.3%32.9%32.8%32.5%32.6%32.5%32.5%31.6%32.2%31.8%31.0%30.5%29.2%29.1%29.6%26.3%25.5%30.9%31.7%30.0%30.4%31.5%32.1%28.2%27.5%27.0%26.8%25.5%27.4%25.0%25.5%21.1%
Finance costs305236454856565764758080911031071026957627168739192102102111116122123133126122121
Depreciation593508206204201201199198197203213201191196193163162167168165165167165161168163163160160156152150151
Profit before tax733529814791738665691661656631631559531433419463−87357472484383357384402293319296279−150275205232134
Tax1671651792001901671882081991821881731531461361513110815615459607481−216852632292669−94
Net profit566364635591548498503453457449443386378287283312−118249316330324297310321314251244216−152246179163228
Net margin11.5%8.7%19.2%17.9%17.2%16.8%17.9%15.7%16.0%16.4%16.2%14.5%14.6%11.5%11.4%13.6%-5.5%11.8%14.8%15.5%16.7%14.9%15.4%15.6%16.1%12.8%12.2%10.7%-8.2%12.0%9.5%8.7%13.2%
EPS (₹)14.8711.5118.7717.4516.1914.7114.8813.3713.5113.2713.1011.3911.188.488.369.22-6.9814.7518.6319.5319.1617.5218.3218.9818.5614.7714.4812.74-8.9514.5010.579.6613.55
Net profit YoY+3.3%−26.9%+26.2%+30.5%+19.9%+10.9%+13.5%+17.4%+20.9%+56.4%+56.5%+23.7%–+343.2%+13.7%−1.3%−136.4%−16.2%+1.9%+2.8%+3.2%+18.3%+27.0%+48.6%+306.6%+2.0%+36.3%+32.5%−166.7%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19FY18
Revenue from operations13,98011,51610,7289,6208,5088,0057,9397,6736,002
Other income−942358451975712257299
Total expenses10,9258,8428,5227,8186,9946,5366,8746,8115,370
EBITDA4,5593,7213,3682,8422,4312,4852,1701,9841,349
EBITDA margin32.6%32.3%31.4%29.5%28.6%31.0%27.3%25.9%22.5%
Finance costs385252354333255358451504308
Depreciation1,119795808707662658654618409
Profit before tax2,8722,6732,3521,8471,2261,5261,187562931
Tax734762696602449274162126253
Net profit2,1381,9111,6561,2457771,2521,025436678
Net margin15.3%16.6%15.4%12.9%9.1%15.6%12.9%5.7%11.3%
EPS (₹)63.9256.4748.9436.7945.9373.9860.5525.7840.07
Net profit YoY+11.9%+15.4%+33.0%+60.2%−37.9%+22.1%+135.1%−35.7%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow3,0232,5853,2662,3681,803
Investing cash flow−12,713−540−168−2,356−198
Financing cash flow10,151−2,298−2,77977−1,781
Capital expenditure677611433574203
Free cash flow (CFO − capex)2,3461,9742,8331,7941,600

Net profit trend

annual, ₹ crore
FY21
₹1,252
FY22
₹777−38%
FY23
₹1,245+60%
FY24
₹1,656+33%
FY25
₹1,911+15%
FY26
₹2,138+12%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated30 Jul 2026PDF on NSE XBRL
Q1 FY27Standalone30 Jul 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited22 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited23 May 2026PDF on NSE XBRL
Q3 FY26Consolidated13 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone · audited13 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated7 Nov 2025 PDF XBRL
Q2 FY26Standalone · audited7 Nov 2025 PDF XBRL
Q1 FY26Consolidated28 Jul 2025 PDF XBRL
Q1 FY26Standalone · audited28 Jul 2025 PDF XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 54.7×78.3×
P/B5Y avg 12.60×20.13×
ROEFY26, on average equity26.8%
Net margin15.3%
Debt / equity1.76×
Revenue CAGR (3Y)13.3%
Profit CAGR (3Y)19.8%
EPS (TTM)₹63.70
Market cap₹1.69L Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
20.13×
vs 8-point avg 12.60× (+60%)
8.39× low12.60× avg20.13× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹44,312 Cr+196%
Net worth₹8,389 Cr+11%
Total borrowings₹14,798 Cr+389%
Cash & bank balances₹1,117 Cr+95%
Investments₹949 Cr+508%
Inventories₹3,138 Cr+23%
Trade receivables₹3,031 Cr+62%
Trade payables₹2,358 Cr+30%
Change vs the same date a year earlier.
Shareholding 20 Jul 2026
%Jul 26Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23
Promoter60.7868.3168.3168.3168.3168.3168.3168.3171.2571.2571.2571.25
FII17.9715.4416.1816.1315.9216.0916.3116.1714.4614.2214.1414.09
DII12.879.839.069.149.288.658.358.357.087.277.267.21
of which MF8.274.944.454.835.124.95––––––
Retail6.825.044.114.034.074.444.514.614.343.984.084.15
Other public1.561.382.342.392.422.512.522.562.873.283.273.30
1,40,599 shareholders · NSE shareholding pattern filings.